CCN2 and idiopathic pulmonary fibrosis: Treatment of IPF fibroblasts with BIX01294 potently upregulated CEBPA expression (Fig. 4a) and reduced the transcripts for pro-fibrotic genes ACTA2, COL1A1, FN1, and CTGF in these cells (Fig. 4e-h).